MBS items for drug eluting stents under review

The government is to review MBS items for drug eluting stents to evaluate whether they represent value for money.

In a draft review scope for percutaneous coronary artery interventions, the Medicare Services Advisory Committee said the review would “consider the best available evidence relevant to the use of drug eluting stents in cardiology services and compare that to evidence related to the use of bare metal stents.”

The MSAC announcement said the